Iulia Iatan, MD PhD (@iuliaiatan) 's Twitter Profile
Iulia Iatan, MD PhD

@iuliaiatan

Cardiovascular Prevention and Cardiometabolic Health @UBC @HLIStPauls | General Internist | PCE @HarvardHSPH | Grad @McGillU

ID: 1580790728288264193

calendar_today14-10-2022 05:21:34

172 Tweet

541 Followers

500 Following

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

#APICAT trial at #ACC25 #LBCT #cardioonc 🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE 🩸more than half female! 👏🏽👏🏽 🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed 🩸no increase in deaths

#APICAT trial at #ACC25 #LBCT #cardioonc

🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint  recurrent VTE
🩸more than half female! 👏🏽👏🏽
🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed
🩸no increase in deaths
International Atherosclerosis Society (IAS) (@atherosociety) 's Twitter Profile Photo

Over the last two weeks, each of the society's four regional federations met virtually for the first time for the new term (2025-2027). IAS’ regional federations are integral to advancing the society’s mission and are designed to facilitate and broaden IAS activities at a

Over the last two weeks, each of the society's four regional federations met virtually for the first time for the new term (2025-2027).

IAS’ regional federations are integral to advancing the society’s mission and are designed to facilitate and broaden IAS activities at a
Dr Meral Kayikcioglu (@meralkayikcoglu) 's Twitter Profile Photo

Full house at the 8th EAS Paediatric FH Symposium! Growing interest each year. Key message: we need updated pediatric FH guidelines & better diagnostic scoring tools in young FH. #EASCongress2025 #PediatricFH #Lipidology EAS Congress European Atherosclerosis Society Jeanine RvL Jamal Rana, MD

Full house at the 8th EAS Paediatric FH Symposium! Growing interest each year. 
Key message: we need updated pediatric FH guidelines & better diagnostic scoring tools in young FH. 
#EASCongress2025 #PediatricFH #Lipidology  <a href="/EASCongress/">EAS Congress</a> <a href="/society_eas/">European Atherosclerosis Society</a>  <a href="/j_rvl/">Jeanine RvL</a> <a href="/JamalRanaMD/">Jamal Rana, MD</a>
EAS Congress (@eascongress) 's Twitter Profile Photo

Ever wondered how to win a Nobel Prize? Step 1: Make a discovery Step 2: Change the game Step 3: Benefit humankind Forget your H-index—impact comes first. Insights from Göran K. Hansson at #EASCongress2025

Ever wondered how to win a Nobel Prize?
Step 1: Make a discovery
Step 2: Change the game
Step 3: Benefit humankind

Forget your H-index—impact comes first.
Insights from Göran K. Hansson at #EASCongress2025
Taher Modarressi, M.D. (@tmodarressi) 's Twitter Profile Photo

Phenomenal talk by Michael D. Shapiro at #EASCongress2025 highlighting the role and potency of remnant particles (remnant cholesterol, rather than their TG content) in atherosclerosis.

Phenomenal talk by <a href="/DrMichaelShapir/">Michael D. Shapiro</a> at #EASCongress2025 highlighting the role and potency of remnant particles (remnant cholesterol, rather than their TG content) in atherosclerosis.
EAS Congress (@eascongress) 's Twitter Profile Photo

Not all particles are created equal. Elias Björnson is asking: Which lipoproteins truly drive risk—LDL, remnants, or Lp(a)? Anitschkow Hall is packed at #EASCongress2025—clearly, lipidology still has secrets worth uncovering.

Not all particles are created equal.
Elias Björnson is asking: Which lipoproteins truly drive risk—LDL, remnants, or Lp(a)?
Anitschkow Hall is packed at #EASCongress2025—clearly, lipidology still has secrets worth uncovering.
International Atherosclerosis Society (IAS) (@atherosociety) 's Twitter Profile Photo

Taking advantage of the #EASCongress in Glasgow, IAS' Board of Directors and Regional Federation members convened for an in-person meeting, complemented by virtual participation from 8 additional board members. This opportunity for face-to-face planning is essential for future

Taking advantage of the #EASCongress in Glasgow, IAS' Board of Directors and Regional Federation members convened for an in-person meeting, complemented by virtual participation from 8 additional board members.

This opportunity for face-to-face planning is essential for future
Federica Fogacci (@federicafogacci) 's Twitter Profile Photo

Plaque imaging can be used as a surrogate endpoint in clinical trials. First measure of efficacy? % change in non-calcified plaque volume. But in clinical practice, how can we effectively compare serial results? #EASCongress2025 #MyEAS2025 EAS Congress European Atherosclerosis Society

Plaque imaging can be used as a surrogate endpoint in clinical trials. First measure of efficacy? % change in non-calcified plaque volume. But in clinical practice, how can we effectively compare serial results? #EASCongress2025 #MyEAS2025 <a href="/EASCongress/">EAS Congress</a> <a href="/society_eas/">European Atherosclerosis Society</a>
Federica Fogacci (@federicafogacci) 's Twitter Profile Photo

Risk of recurrent ASCVD increases steadily with higher Lp(a) levels, similarly in women, men, and across racial groups (Black, Hispanic, White). This relationship may be reduced with high-impact LLT, especially PCSK9 inhibitors Borge G Nordestgaard #EASCongress2025 #MyEAS2025

Risk of recurrent ASCVD increases steadily with higher Lp(a) levels, similarly in women, men, and across racial groups (Black, Hispanic, White). This relationship may be reduced with high-impact LLT, especially PCSK9 inhibitors <a href="/BNordestgaard/">Borge G Nordestgaard</a> #EASCongress2025 #MyEAS2025
Taher Modarressi, M.D. (@tmodarressi) 's Twitter Profile Photo

ANGPTL4 mAb with seemingly robust impacts in TG and remnant cholesterol, accentuated impact in those with TG>200. Presented by Ethan J. Weiss at #EASCongress2025

ANGPTL4 mAb with seemingly robust impacts in TG and remnant cholesterol, accentuated impact in those with TG&gt;200. Presented by <a href="/ethanjweiss/">Ethan J. Weiss</a> at #EASCongress2025
Federica Fogacci (@federicafogacci) 's Twitter Profile Photo

Exciting new European Atherosclerosis Society Consensus Statement on clinical staging to guide actionable management of systemic metabolic disorders and their sequelae Stefano Romeo #MyEAS2025 #EASCongress2025

Exciting new European Atherosclerosis Society Consensus Statement on clinical staging to guide actionable management of systemic metabolic disorders and their sequelae <a href="/stefano_romeo76/">Stefano Romeo</a> #MyEAS2025 #EASCongress2025
Dr Rob 🫀🩺 🇦🇺 (@drhungo) 's Twitter Profile Photo

📉 Obicetrapib ⤵️ LDL-C by 24–33% and Lp(a) by 33.5%, with half achieving LDL-C <55 mg/dL. Well tolerated, no safety issues, and under outcomes review in PREVAIL. ⁉️ Emerging contender for high-risk lipid lowering 🔗 nejm.org/doi/full/10.10… #CardioTwitter #FOAMed

📉 Obicetrapib ⤵️ LDL-C by 24–33% and Lp(a) by 33.5%, with half achieving LDL-C &lt;55 mg/dL. 

Well tolerated, no safety issues, and under outcomes review in PREVAIL.

⁉️  Emerging contender for high-risk lipid lowering

🔗 nejm.org/doi/full/10.10…

#CardioTwitter #FOAMed
International Atherosclerosis Society (IAS) (@atherosociety) 's Twitter Profile Photo

Introducing the next Regional Federation - Americas. Regional federations help IAS by strengthening relationships & collaborations with IAS members and facilitating new relationships between IAS and relevant organizations with similar objectives. This group of doctors is

Introducing the next Regional Federation - Americas.

Regional federations help IAS by strengthening relationships &amp; collaborations with IAS members and facilitating new relationships between IAS and relevant organizations with similar objectives.

This group of doctors is
Pablo Corral MD (@drpablocorral) 's Twitter Profile Photo

📢 Essential Reading – 2025 Landmark Paper on Lp(a) The Brussels International Declaration on Lipoprotein(a) Testing and Management, published in Atherosclerosis, represents the most comprehensive and authoritative document on Lp(a) to date. ☝️Highlights: 1️⃣ Establishes global

📢 Essential Reading – 2025 Landmark Paper on Lp(a)

The Brussels International Declaration on Lipoprotein(a) Testing and Management, published in Atherosclerosis, represents the most comprehensive and authoritative document on Lp(a) to date.

☝️Highlights:
1️⃣ Establishes global
Liam Brunham (@liambrunham) 's Twitter Profile Photo

Our case report: Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication | JACC: Case Reports jacc.org/doi/10.1016/j.…

ASPC (@aspcardio) 's Twitter Profile Photo

🎉 Congratulations to our ASPC 2025 Scholarship recipients! We can’t wait to welcome you to #ASPC2025 and see the future of preventive cardiology in action. 🔗 Learn more: ow.ly/qTvX50WtH5F #PreventiveCardiology #HeartHealth #ASPCScholarship #MedicalEducation

🎉 Congratulations to our ASPC 2025 Scholarship recipients!

We can’t wait to welcome you to #ASPC2025 and see the future of preventive cardiology in action.

🔗 Learn more: ow.ly/qTvX50WtH5F

#PreventiveCardiology #HeartHealth #ASPCScholarship #MedicalEducation